MASS News and Press, 908 Devices Inc. From 12/17/23

2023-12-17 18:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-28 07:50:06 ET Summary MASS recently announced quarterly results showing weakness, with declining revenue, widened loss, and declining margins. The stock price has already experienced a significant correction, but there is still no buying opportunity due to financial and t...

Broadens the reach of trace detection and identification at the point of need to enhance safety 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced that it has expanded access to its leading ...

2023-11-07 13:55:03 ET 908 Devices Inc. (MASS) Q3 2023 Earnings Call Transcript November 7, 2023 08:30 AM ET Company Participants Kelly Gura - IR Kevin Knopp - Co-Founder, CEO, President & Director Joseph Griffith - CFO & Treasurer Conference Call P...

2023-11-07 07:10:38 ET More on 908 Devices 908 Devices: Not Worth Investing 908 Devices awarded $10.4M order from U.S. Air Force for its handheld MX908 device Seeking Alpha’s Quant Rating on 908 Devices Historical earnings data for 908 Devices ...

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended September 30, 2023. "We are pleased with the step-up in our revenues from the second quarter and the positive ...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

908 Devices Inc. (MASS) is expected to report $-0.3 for Q3 2023

Automation combined with on-line monitoring during the cell expansion step can bring cell therapy manufacturing efficiencies and enable increased patient accessibility and safety 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical an...

2023-11-06 14:48:57 ET More on 908 Devices 908 Devices: Not Worth Investing 908 Devices, Inc. (MASS) Q2 2023 Earnings Call Transcript 908 Devices awarded $10.4M order from U.S. Air Force for its handheld MX908 device Seeking Alpha’s Quant Rating on 908...